Gill Louise Buchanan, MBChB; Alaide Chieffo, MD; Chiara Bernelli, MD; Matteo Montorfano, MD; Mauro Carlino, MD; Azeem Latib, MD; Filippo Figini, MD; Francesco Giannini, MD; Alessandro Durante, MD; Alfonso Ielasi, MD; Alfredo Castelli, MD; Antonio Colombo*, MD
San Raffaele Scientific Institute, Milan, Italy
Aims: To assess two-year outcomes following first vs. new-generation drug-eluting stent (DES) implantation in unprotected left main (ULMCA) percutaneous coronary intervention.